All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma

PURPOSE: Peripheral T-cell lymphoma (PTCL) is a rare and heterogenous hematologic malignancy with poor prognosis especially in elderly and frail patients who are not eligible for intensive treatment. The resulting palliative setting necessitates tolerable but effective schedules for outpatient treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fante, Matthias A., Harrer, Dennis C., Zartner, Barbara, Lüke, Florian, Mayer, Stephanie, Menhart, Karin, Reichle, Albrecht, Herr, Wolfgang, Vogelhuber, Martin, Heudobler, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250661/
https://www.ncbi.nlm.nih.gov/pubmed/37305564
http://dx.doi.org/10.3389/fonc.2023.1177330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250661/
https://www.ncbi.nlm.nih.gov/pubmed/37305564
http://dx.doi.org/10.3389/fonc.2023.1177330

Ejemplares similares